Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 2:14 pm Sale | 13G | GAMIDA CELL LTD GMDA | CVI Investments Inc. | 6,966,279 4.9% | -33,721 (-0.48%) | View |
2024-02-14 2:14 pm Unchanged | 13G | EBANG INTL HLDGS INC EBON | CVI Investments Inc. | 343,332 6.8% | 0 (Unchanged) | View |
2024-02-14 2:14 pm Purchase | 13G | NOGIN INC NOGN | CVI Investments Inc. | 1,252,857 9.9% | 1,252,857 (New Position) | View |
2024-02-01 10:22 am Purchase | 13G | REDHILL BIOPHARMA LTD RDHL | CVI Investments Inc. | 700,000,000 5.9% | 700,000,000 (New Position) | View |
2023-12-01 2:31 pm Purchase | 13G | BITFARMS LTD COM BITF | CVI Investments Inc. | 18,518,520 5.7% | 18,518,520 (New Position) | View |
2023-07-24 12:17 pm Purchase | 13G | GENPREX INC GNPX | CVI Investments Inc. | 3,465,347 5.8% | 3,465,347 (New Position) | View |
2023-07-21 10:12 am Purchase | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | CVI Investments Inc. | 207,573 9.9% | 207,573 (New Position) | View |
2023-04-26 11:21 am Purchase | 13G | SIDUS SPACE INC SIDU | CVI Investments Inc. | 2,601,009 7.7% | 2,601,009 (New Position) | View |
2023-04-24 10:12 am Purchase | 13G | GAMIDA CELL LTD GMDA | CVI Investments Inc. | 7,000,000 6.6% | 7,000,000 (New Position) | View |
2023-04-21 10:02 am Purchase | 13G | EOS ENERGY ENTERPRISES INC EOSE | CVI Investments Inc. | 8,000,000 7% | 8,000,000 (New Position) | View |
2023-02-28 10:55 am Purchase | 13G | ENSERVCO CORPORATION ENSV | CVI Investments Inc. | 1,000,000 6.3% | 1,000,000 (New Position) | View |
2023-02-21 11:10 am Purchase | 13G | MIDATECH PHARMA PLC SPONSORED MTP | CVI Investments Inc. | 10,834,000 6.2% | 10,834,000 (New Position) | View |
2023-02-14 5:14 pm Unchanged | 13G | ROYALTY MGMT HLDG CORP RMCO | CVI Investments Inc. | 0 0% | 0 (Unchanged) | View |
2023-02-14 11:28 am Sale | 13G | AURORA CANNABIS INC ACB | CVI Investments Inc. | 15,779,211 4.9% | -720,789 (-4.37%) | View |
2023-02-14 11:26 am Purchase | 13G | TIAN RUIXIANG HLDGS LTD O TIRX | CVI Investments Inc. | 133,333 4.9% | 133,333 (New Position) | View |
2023-02-14 11:25 am Sale | 13G | QUOIN PHARMACEUTICALS LTD QNRX | CVI Investments Inc. | 1,272,737,541 4.9% | -227,262,459 (-15.15%) | View |
2023-02-14 11:25 am Purchase | 13G | RYVYL INC RVYL | CVI Investments Inc. | 5,417,160 9.9% | 459,211 (+9.26%) | View |
2023-02-14 11:24 am Purchase | 13G | EVOFEM BIOSCIENCES INC EVFM | CVI Investments Inc. | 7,033,373 5.5% | 7,033,373 (New Position) | View |
2023-02-14 11:24 am Sale | 13G | BENITEC BIOPHARMA INC BNTC | CVI Investments Inc. | 1,469,593 4.9% | -30,407 (-2.03%) | View |
2023-02-14 11:23 am Purchase | 13G | AYTU BIOPHARMA INC PAR $0. AYTU | CVI Investments Inc. | 3,278,844 4.9% | 3,278,844 (New Position) | View |